Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of Epirubicin and Taxotere in Patients With Metastatic Androgen Independent Prostate Cancer

NCT00096304 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT00096304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00096304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of Epirubicin and Taxotere in Patients With Metastatic Androgen Independent Prostate Cancer
Lead sponsor
Medical University of South Carolina
Phase
Phase 1
Overall status
Terminated
Start date
June 8, 2004
Completion date
November 30, 2007
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer